273 related articles for article (PubMed ID: 4897238)
1. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
Pearson JM; Pettit JH
Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
Waters MF
Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
[No Abstract] [Full Text] [Related]
3. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
Languillon J; Yawalkar SJ; McDougall AC
Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
[No Abstract] [Full Text] [Related]
4. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
5. The continuous bacteremia of lepromatous leprosy.
Drutz DJ; Chen TS; Lu WH
N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
[No Abstract] [Full Text] [Related]
6. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
Browne SG
Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
[No Abstract] [Full Text] [Related]
7. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
8. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
9. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
[No Abstract] [Full Text] [Related]
10. [2 cases of paucibacillary leprosy resistant to dapsone].
Janssens L
Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
[TBL] [Abstract][Full Text] [Related]
11. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
[TBL] [Abstract][Full Text] [Related]
12. Low dose dapsone therapy in lepromatous leprosy.
Karat AB
Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
[No Abstract] [Full Text] [Related]
13. A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
Am J Trop Med Hyg; 1978 Sep; 27(5):1005-14. PubMed ID: 362950
[No Abstract] [Full Text] [Related]
14. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Fieldsteel AH; Levy L
Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
[TBL] [Abstract][Full Text] [Related]
15. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
Waters MF; Rees RJ; McDougall AC; Weddell AG
Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
[No Abstract] [Full Text] [Related]
16. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
Waters MF; Pettit JH
Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
[No Abstract] [Full Text] [Related]
17. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
[No Abstract] [Full Text] [Related]
18. Relapse rates in lepromatous leprosy according to treatment regularity.
Almeida JG; Jesudasan K; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):16-20. PubMed ID: 3519802
[TBL] [Abstract][Full Text] [Related]
19. Importance of nasal lesions in early lepromatous leprosy.
Barton RP
Ann R Coll Surg Engl; 1975 Dec; 57(6):309-12. PubMed ID: 1108744
[TBL] [Abstract][Full Text] [Related]
20. Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
Quagliato R; Bechelli LM; Marques RM
Int J Lepr Other Mycobact Dis; 1970; 38(3):250-63. PubMed ID: 4993550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
